HomeCompareAMNZF vs MRK

AMNZF vs MRK: Dividend Comparison 2026

AMNZF yields 1000000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMNZF wins by $188409716392645591040.00M in total portfolio value
10 years
AMNZF
AMNZF
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$188409716392645591040.00M
Annual income
$156,820,396,180,463,870,000,000,000.00
Full AMNZF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AMNZF vs MRK

📍 AMNZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMNZFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMNZF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMNZF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMNZF
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$133,297,336,753,394,290,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, AMNZF beats the other by $133,297,336,753,394,290,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMNZF + MRK for your $10,000?

AMNZF: 50%MRK: 50%
100% MRK50/50100% AMNZF
Portfolio after 10yr
$94204858196322795520.00M
Annual income
$78,410,198,090,231,930,000,000,000.00/yr
Blended yield
83.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AMNZF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMNZF buys
0
MRK buys
0
No recent congressional trades found for AMNZF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMNZFMRK
Forward yield1000000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$188409716392645591040.00M$56.8K
Annual income after 10y$156,820,396,180,463,870,000,000,000.00$9,798.13
Total dividends collected$186170298512243982336.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AMNZF vs MRK ($10,000, DRIP)

YearAMNZF PortfolioAMNZF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,206$366.19+$50.00MAMNZF
2$116,900,941,356$116,847,429,906.54$12,650$502.35+$116900.93MAMNZF
3$127,757,345,946,658$127,632,261,939,407.38$14,407$694.19+$127757345.93MAMNZF
4$65,316,731,768,579,704$65,180,031,408,416,776.00$16,585$967.82+$65316731768.56MAMNZF
5$15,641,708,257,005,480,000$15,571,819,354,013,100,000.00$19,342$1,363.89+$15641708257005.46MAMNZF
6$1,759,286,910,766,321,500,000$1,742,550,282,931,325,600,000.00$22,913$1,947.19+$1759286910766321.50MAMNZF
7$93,467,370,779,778,750,000,000$91,584,933,785,258,800,000,000.00$27,662$2,823.89+$93467370779778752.00MAMNZF
8$2,373,712,470,630,401,000,000,000$2,273,702,383,896,037,800,000,000.00$34,159$4,173.35+$2373712470630401024.00MAMNZF
9$29,522,729,170,263,285,000,000,000$26,982,856,826,688,750,000,000,000.00$43,337$6,308.80+$29522729170263285760.00MAMNZF
10$188,409,716,392,645,600,000,000,000$156,820,396,180,463,870,000,000,000.00$56,776$9,798.13+$188409716392645591040.00MAMNZF

AMNZF vs MRK: Complete Analysis 2026

AMNZFStock

As of March 26, 2015, Ambrian Plc was acquired by Consolidated General Minerals plc, in a reverse merger transaction. Ambrian plc, through its subsidiaries, provides commodity trading services to refined copper producers and consumers in the United Kingdom and internationally. The company operates as a physical metals merchant that offers sourcing, logistics, and financing services principally for copper cathode and copper wire rods. It also arranges and manages strategic investments. The company was formerly known as East West Resources plc and changed its name to Ambrian plc in August 2014. Ambrian plc was incorporated in 1996 and is based in London, the United Kingdom.

Full AMNZF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AMNZF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMNZF vs SCHDAMNZF vs JEPIAMNZF vs OAMNZF vs KOAMNZF vs MAINAMNZF vs JNJAMNZF vs ABBVAMNZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.